Volume 5 Supplement 1
Effects of molecular and functional intestinal adaptation to chronic LPS administration
© The Author(s) 2001
Received: 15 January 2001
Published: 2 March 2001
We and others have shown that a single injection of LPS or IM alone triggers an acute molecular and cellular inflammatory response within the intestinal muscularis which results in ileus. We also have shown in unpublished data, that LPS potentiates the inhibitory effects of intestinal manipulation on the small intestine. It is known, that LPS induces adaptational processes. The objective of this study was to investigate the effect of molecular preconditioning of the intestine by continous LPS administration and its potential cross-adaptation towards other insults.
SD rats were treated daily with an i.p. injection of LPS (1 or 12.5 mg/kg) for 1 or 7 consecutive days (n = 4, P < 0.05). Gentle intestinal manipulation (IM) was performed 24 h after the last LPS administration. Jejunal circular muscle strips were functionally evaluated using organ bath recordings 24 h after intestinal manipulation. MPO staining was assessed to measure the neutrophil recruitment into the muscularis. RT-PCR and electrophoretic mobility shift assays (EMSAs) were performed on isolated jejunal muscularis extracts.
EMSA for NF-κB, NF-IL-6 and STAT3 showed a 3.2-, 3.8-and 8.6-fold increase in activation in the jejunal muscularis 3 h after IM compared to controls. This transcriptional response demonstrated significant adaptation when doing the manipulation with the 7th consecutive administration with only a 3.1-, 4.0- and 3.0- fold activation of NF-κB, NF-IL-6 and STAT3 3 h after manipulation following the 7th LPS injection. RT-PCR showed an acute significant 6.0-fold upregulation in IL-6 mRNA within the muscularis 3 h after IM, which was significantly increased after a single LPS administration but adapted to a 3.8-fold increase at IM after 7 days of LPS pretreatment. Similar quantitative observations were also made for TNF-α and iNOS. Functionally, IM caused a significant suppression of in vitro contractility (24h after IM = 0.53 ± 0.047 vs Control = 1.26 ± 0.07 g/mm2/s at 300 μM bethanechol). However, chronically LPS injected animals had contractile responses similar to control (1.28 ± 0.02 g/mm2/s, at 300 μM bethanechol). IM following this LPS preconditioning didn't affect the bethanechol stimulated response compared to controls (1.02 ± 0.08 g/mm2/s, at 300 μM bethanechol).
We conclude that significant intestinal adaptation occurs in response to chronic LPS through a down-regulation in the inflammatory milieu and a significant recovery in in vitro muscle contractility.